Belviq is the first weight loss treatment to be approved for more than a decade. It is intended for obese adults who are either at risk of developing weight-related complications or already have a condition such as high cholesterol or diabetes. It works by stimulating a sensation of satiety in the brain; in other words, it has an appetite suppressing effect.
Currently Belviq is not available in the UK, but the FDA in the US has approved it and as such it is expected to launch in 2013. In spite of fears that the treatment might increase the risk of tumour development, it was found that there is very little risk of this happening in people.
What are the benefits of using Belviq?
Belviq is an FDA approved treatment that has shown promising results during clinical trials. Most patients who used it during clinical trails noticed a 5% decrease in their body weight within a 12 week period.
Belviq, once it is launched in the UK, will provide those who are at an increased risk of health complications as a result of their weight with an alternative treatment option to Xenical, formerly the only prescription treatment for weight loss available in the UK. Xenical works in the digestive system to regulate the absorption of fats. Although it's effective, some people may be more prone to gastrointestinal side effects, which is a significantly lower risk with Belviq.
How does Belviq work?
Many people who are struggling with their weight find it difficult to regulate the portions they consume. Belviq aims to help with portion control by allowing people to feel fuller quicker from smaller portions. It is able to do this because it influences satiety-related hormone balances in the brain. This is because it is a serotonin 2C receptor agonist.
Serotonin is a neurotransmitter that relays messages and plays a part in many different mood related processes in our brain and also lets us know whether or not we are full. Belviq acts on receptors in the brain, having the same effect as the natural neurotransmitters in the brain, causing you to feel full quicker than you normally would.
Who can take it?
Belviq will only be recommended to people with a BMI over 27 who already suffer from a weight related condition, such as high cholesterol or diabetes, or people with a BMI over 30. It will strictly be available in a 12 week course and those who do not experience a weight loss goal that entails a loss of at least 5% of their original weight will be required to seek another treatment.
It is also not recommended to those who are already using a treatment such as Xenical and St John's Wort or women who are pregnant or breastfeeding. People who are already receiving treatment for depression or migraines may have to use this treatment with caution, as they could be more likely to develop side effects.
How do you take it?
One 10mg Belviq tablet should be taken twice daily with or without food. To ensure that you achieve optimum results, this treatment should be used to supplement a calorie controlled diet and regular exercise. If you are finding it difficult to stay active, you can ask your doctor for advice.
Are there any side effects?
Like any prescription weight loss treatment, taking Belviq carries a small risk of side effects. It's unlikely that these side effects will be serious and most of them should disappear as the body starts to get used to the main ingredient, lorcasarin. Common side effects that have been reported include headaches, nausea, dizziness, constipation, back pain, cough, dry mouth or fatigue. If these effects persist or you experience anything worrying, contact your doctor immediately.
Can you buy Belviq online?
Belviq is currently not available in the UK, however its estimated release date is 2013. Please keep an eye on our blog for any further updates regarding the availability of Belviq. If you require a treatment for obesity, Xenical is currently the only UK-approved prescription medication that is available.